Clinical Trials
3 trialsNCT07629700 2026-06-05
ENDEAVOR
University of Florence
Phase NA Not yet recruiting
NCT07484022 2026-06-03
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
Generate Biomedicines
Phase 1 Recruiting
NCT07548476 2026-05-04
ACE
Dana-Farber Cancer Institute
Phase NA Not yet recruiting